Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

ECG-AI® Instructions for Use

Thank you for your interest in Anumana’s ECG-AI® algorithms.

To access the Clinician’s Instructions for Use (IFU) for ECG-AI, please complete the contact form below. An Anumana team member will reach out with the details.
Please note that ECG-AI is currently only commercially available in the United States.

If you’re not yet a customer and would like to schedule a demo please complete the form below, and we’ll arrange a convenient time to introduce the product to you and your team.

Request type(Required)
Please select the algorithm(s) you are interested in
Consent(Required)